REFERENCES

ATP III Risk Factors

LDL Goal and Treatment According to Risk Category by Update to ATP III

Risk Category LDL-Cholesterol Goal LDL Level at which to Initiate Therapeutic Lifestyle Changes (TLC) When to begin Medications

High Risk:
CHD or CHD Risk Equivalents (10-year risk > 20%)


< 100 mg/dL

(optional goal: <70 mg/dL)


≥ 100 mg./dL

≥ 100 mg/dL

(< 100 mg/dL: consider drug options)

Moderately High Risk:
2+ Risk Factors (10-year risk 10%-20%)



< 130 mg/dL


≥ 130 mg/dL
≥ 130 mg/dL
(100-129 mg/dL, consider drug options)

Moderate Risk:
2+ Risk Factors (10-year risk <10%)

 

< 130 mg/dL



≥ 130 mg/dL


≥ 160 mg/dL
Lower Risk:
0-1 Risk Factor


< 160 mg/dL


≥ 160 mg/dL
≥ 190 mg/dL
(160-190 mg/dL; LDL-lowering drug optional
Source: Adapted from Grundy SM et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.

 

 


Major Risk Factors (exclusive of LDL Cholesterol) that Modify LDL Goal

LDL Goal and Treatment According to Risk Category by Update to ATP III

Clinical Identification of Metabolic Syndrome

BMI Calculator

Components of Therapeutic Lifestyle Changes (TLC)

Insulin Resistance and Clinical Parameters

Bibliography



Page 2 of 7